E1-E4-deleted Ad.RSVtk (University of Pennsylvania/Wistar Institute)

N/A

Report date: 2023/10/26 16:14:53

Base Information

Drug NameE1-E4-deleted Ad.RSVtk (University of Pennsylvania/Wistar Institute)
Drug Alias Nameadenoviral gene therapy (HSV-tk, mesothelioma) (University of Pennsylvania/Wistar Institute)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsMesothelioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWistar InstituteUniversity Of Pennsylvania
Active IndicationsN/A
Inactive IndicationsMesothelioma

Other Information

ATC CodeN/A
Related LinksN/A